Athanasios Tsiatis

Company: ALX Oncology

Job title: Senior Vice President - Clinical Development

Seminars:

Combining Targeted Agents with Checkpoint Inhibitors 5:00 pm

• Delving into PD-L1 combination studies • Understanding rationale depending on drug pathology • Clinical data comparisons • Relevance to treatment regimes and study designRead more

day: Day One